Groupe de Recherche sur les formes Injectables et les Technologies Associées (GRITA)

Web site

Administrative institutions

Université de Lille
CHU Lille

Presentation

Les axes de recherche développés au sein du Groupe de Recherche sur les formes Injectables et les Technologies Associées (GRITA) sont orientés vers les médicaments injectables, les dispositifs médicaux de perfusion et la modélisation biopharmaceutique et pharmacocinétique. L'unité est une équipe d'accueil (EA 7365) sous la tutelle de l'Université de Lille et du CHU de Lille.

Research teams

Innovation/évaluation des dispositifs médicaux de perfusion
Innovation/évaluation des médicaments injectables
Modélisation biopharmaceutique et pharmacocinétique

Groupe de Recherche sur les formes Injectables et les Technologies Associées (GRITA) - ULR 7365

Web site

Administrative institutions

Presentation

Research teams

Recent Submissions

Safety and Efficacy of Tinostamustine in a Subpopulation of Patients With Relapsed/Refractory Hodgkin Lymphoma From a Phase I Trial.

Phase IB part of LOC-R01, a LOC network non-comparative randomized phase IB/II study testing R-MPV in combination with escalating doses of lenalidomide or ibrutinib for newly diagnosed primary central nervous system lymphoma (PCNSL) patients

Classic Hodgkin Lymphoma: The LYSA pragmatic guidelines

Building the Future Management of Follicular Lymphoma with T-Cell-Redirecting Strategies

Use of two general-purpose scales to assess clinical pharmacy activities in a cell transplantation unit

Potential Sampling Errors in Stability Studies Due to Dead Volume in Closed System Transfer Devices

Evaluation of the economic impact and the patient pathway in the treatment of chronic total occlusion

Follicular lymphoma comprises germinal center-like and memory-like molecular subtypes with prognostic significance

Integrative metagenomics and metabolomics reveal age-associated gut microbiota and metabolite alterations in experimental COVID-19

Method for the detection and quantification of viral contamination during the preparation of gene therapy drugs in a hospital pharmacy.

Groupe de Recherche sur les formes Injectables et les Technologies Associées (GRITA) - ULR 7365

Web site

Administrative institutions

Presentation

Research teams

Recent Submissions

Safety and Efficacy of Tinostamustine in a Subpopulation of Patients With Relapsed/Refractory Hodgkin Lymphoma From a Phase I Trial. ﻿

Phase IB part of LOC-R01, a LOC network non-comparative randomized phase IB/II study testing R-MPV in combination with escalating doses of lenalidomide or ibrutinib for newly diagnosed primary central nervous system lymphoma (PCNSL) patients ﻿

Classic Hodgkin Lymphoma: The LYSA pragmatic guidelines ﻿

Building the Future Management of Follicular Lymphoma with T-Cell-Redirecting Strategies ﻿

Use of two general-purpose scales to assess clinical pharmacy activities in a cell transplantation unit ﻿

Potential Sampling Errors in Stability Studies Due to Dead Volume in Closed System Transfer Devices ﻿

Evaluation of the economic impact and the patient pathway in the treatment of chronic total occlusion ﻿

Follicular lymphoma comprises germinal center-like and memory-like molecular subtypes with prognostic significance ﻿

Integrative metagenomics and metabolomics reveal age-associated gut microbiota and metabolite alterations in experimental COVID-19 ﻿

Method for the detection and quantification of viral contamination during the preparation of gene therapy drugs in a hospital pharmacy. ﻿

Safety and Efficacy of Tinostamustine in a Subpopulation of Patients With Relapsed/Refractory Hodgkin Lymphoma From a Phase I Trial.

Phase IB part of LOC-R01, a LOC network non-comparative randomized phase IB/II study testing R-MPV in combination with escalating doses of lenalidomide or ibrutinib for newly diagnosed primary central nervous system lymphoma (PCNSL) patients

Classic Hodgkin Lymphoma: The LYSA pragmatic guidelines

Building the Future Management of Follicular Lymphoma with T-Cell-Redirecting Strategies

Use of two general-purpose scales to assess clinical pharmacy activities in a cell transplantation unit

Potential Sampling Errors in Stability Studies Due to Dead Volume in Closed System Transfer Devices

Evaluation of the economic impact and the patient pathway in the treatment of chronic total occlusion

Follicular lymphoma comprises germinal center-like and memory-like molecular subtypes with prognostic significance

Integrative metagenomics and metabolomics reveal age-associated gut microbiota and metabolite alterations in experimental COVID-19

Method for the detection and quantification of viral contamination during the preparation of gene therapy drugs in a hospital pharmacy.